Dr. Maria Grazia Caprio, MD, is a Technologist at the Institute of Biostructures and Bioimaging of the National Research Council (IBB-CNR) in Naples, Italy. She holds a Degree in Medicine and Surgery, a Specialization in Nuclear Medicine. Her expertise focuses on molecular imaging, including PET and PET/CT, and ultrasound imaging, with applications in oncology, immunotherapy, and pediatric diagnostics. Dr. Caprio actively participates in clinical and preclinical research projects aimed at investigating oncological, neurological, and inflammatory diseases, integrating advanced imaging techniques to support early diagnosis, treatment monitoring, and translational research. She has co-authored several peer-reviewed publications, including:
• "Recent Advances in Nuclear Imaging of Receptor Expression to Guide Targeted Therapies in Breast Cancer" (Cancer),
• "A novel therapeutic approach targeting PD-L1 in HNSCC and bone marrow-derived mesenchymal stem cells hampers pro-metastatic features in vitro..." (Cell Communication and Signaling),
• and studies in pediatric and oncological imaging such as "Paediatric ultrasound(J Ultrasound) and "18F-FDG PET, PET/CT and MDCT in breast cancer and locally advanced colorectal cancer"
Her research emphasizes tumor imaging, tumor-stroma communication, and receptor-targeted therapies. She fosters collaborations across clinical and academic networks and contributes to the advancement of translational imaging methodologies.
Dr. Maria Grazia Caprio, MD, is a Technologist at the Institute of Biostructures and Bioimaging of the National Research Council (IBB-CNR) in Naples, Italy. She holds a Degree in Medicine and Surgery, a Specialization in Nuclear Medicine. Her expertise focuses on molecular imaging, including PET and PET/CT, and ultrasound imaging, with applications in oncology, immunotherapy, and pediatric diagnostics. Dr. Caprio actively participates in clinical and preclinical research projects aimed at investigating oncological, neurological, and inflammatory diseases, integrating advanced imaging techniques to support early diagnosis, treatment monitoring, and translational research. She has co-authored several peer-reviewed publications, including:
• "Recent Advances in Nuclear Imaging of Receptor Expression to Guide Targeted Therapies in Breast Cancer" (Cancer),
• "A novel therapeutic approach targeting PD-L1 in HNSCC and bone marrow-derived mesenchymal stem cells hampers pro-metastatic features in vitro..." (Cell Communication and Signaling),
• and studies in pediatric and oncological imaging such as "Paediatric ultrasound(J Ultrasound) and "18F-FDG PET, PET/CT and MDCT in breast cancer and locally advanced colorectal cancer"
Her research emphasizes tumor imaging, tumor-stroma communication, and receptor-targeted therapies. She fosters collaborations across clinical and academic networks and contributes to the advancement of translational imaging methodologies.